Right to Left Cardiac Shunt Detection

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 141 participants.

Also called NCT01773252

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 141 participants (enrolled count) (from the registry)
Sponsor
Cardiox Corporation (from the registry)
Registry
  • NCT NCT01773252
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01773252. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-11 (registry gives no type); primary completion 2015-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Right to Left Cardiac Shunt Detection
Acronym
PFO Detection
Condition
Right to Left Shunt
Condition
Patent Foramen Ovale
Condition
Atrial Septal Defect
Intervention (Device)
Flow Detection System
Lead sponsor
Cardiox Corporation (class: industry)

Record details

Record id
cardio:ct-nct01773252
Content hash
9549a043f40b2aaaf4e0b2c273986a754fc2f30594a4fa5715edbd027ed8a128